Used primarily in research settings as an intermediate for synthesizing biologically active compounds. Shows potential in the development of antidiabetic agents due to structural similarity to known biguanide drugs. Also investigated for its antimicrobial properties and ability to modulate enzyme activity in biochemical assays. Its trifluoromethyl phenyl group enhances metabolic stability, making it useful in pharmaceutical design for improving drug half-life. Commonly employed in studies exploring guanidine-based inhibitors and their effects on cellular metabolism.